NYSE:CFX

Colfax Stock Forecast, Price & News

$43.52
-1.22 (-2.73 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$43.47
$44.48
50-Day Range
$41.57
$46.58
52-Week Range
$24.70
$50.26
Volume1.96 million shs
Average Volume1.43 million shs
Market Capitalization$5.90 billion
P/E Ratio106.15
Dividend YieldN/A
Beta2.21
30 days | 90 days | 365 days | Advanced Chart
Receive CFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Colfax and its competitors with MarketBeat's FREE daily newsletter.


Colfax logo

About Colfax

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.52 out of 5 stars

Industrial Products Sector

135th out of 408 stocks

Pumps & Pumping Equipment Industry

6th out of 8 stocks

Analyst Opinion: 1.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Colfax (NYSE:CFX) Frequently Asked Questions

Is Colfax a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colfax in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Colfax stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CFX, but not buy additional shares or sell existing shares.
View analyst ratings for Colfax
or view top-rated stocks.

What stocks does MarketBeat like better than Colfax?

Wall Street analysts have given Colfax a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Colfax wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Colfax's next earnings date?

Colfax is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Colfax
.

How were Colfax's earnings last quarter?

Colfax Co. (NYSE:CFX) issued its quarterly earnings data on Thursday, April, 29th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.39 by $0.05. The industrial products company had revenue of $879.21 million for the quarter, compared to analyst estimates of $841.42 million. Colfax had a net margin of 1.83% and a trailing twelve-month return on equity of 5.49%.
View Colfax's earnings history
.

How has Colfax's stock been impacted by COVID-19?

Colfax's stock was trading at $25.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CFX shares have increased by 69.7% and is now trading at $43.52.
View which stocks have been most impacted by COVID-19
.

What guidance has Colfax issued on next quarter's earnings?

Colfax issued an update on its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share (EPS) guidance of 2.050-2.150 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.120. The company issued revenue guidance of -.

What price target have analysts set for CFX?

9 brokerages have issued 12 month price objectives for Colfax's shares. Their forecasts range from $6.50 to $57.00. On average, they expect Colfax's stock price to reach $42.45 in the next year. This suggests that the stock has a possible downside of 2.5%.
View analysts' price targets for Colfax
or view top-rated stocks among Wall Street analysts.

Who are Colfax's key executives?

Colfax's management team includes the following people:
  • Mr. Mitchell P. Rales, Co-Founder & Chairman (Age 64, Pay $1)
  • Mr. Matthew L. Trerotola, Pres, CEO & Director (Age 54, Pay $2.41M)
  • Mr. Christopher M. Hix, Exec. VP of Fin. & CFO (Age 59, Pay $1.09M)
  • Mr. Daniel A. Pryor, Exec. VP of Strategy & Bus. Devel. (Age 53, Pay $959k)
  • Mr. Shyam Kambeyanda, Exec. VP and CEO & Pres of ESAB (Age 50, Pay $1.11M)
  • Mr. Brady R. Shirley, CEO of DJO & Exec. VP (Age 55, Pay $1.44M)
  • Mr. Steven L. Breitzka, Interim Sr. VP of Global Operations & Americas (Age 63)
  • Mr. Douglas J. Pitts, VP, Controller & Chief Accounting Officer (Age 62)
  • Mr. Terry Ross, VP of Investor Relations, Strategy & Bus. Devel.
  • Mr. Bradley J. Tandy, Sr. VP, Gen. Counsel & Sec. (Age 62)

What is Matthew Trerotola's approval rating as Colfax's CEO?

2 employees have rated Colfax CEO Matthew Trerotola on Glassdoor.com. Matthew Trerotola has an approval rating of 54% among Colfax's employees. This puts Matthew Trerotola in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Colfax's key competitors?

What other stocks do shareholders of Colfax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colfax investors own include Endologix (ELGX), (APA), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), The Charles Schwab (SCHW), Accenture (ACN), Honeywell International (HON), Micron Technology (MU) and Semtech (SMTC).

What is Colfax's stock symbol?

Colfax trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFX."

Who are Colfax's major shareholders?

Colfax's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (12.72%), BlackRock Inc. (7.03%), Dimensional Fund Advisors LP (4.62%), Diamond Hill Capital Management Inc. (2.41%), Goldman Sachs Group Inc. (2.39%) and Southpoint Capital Advisors LP (2.09%). Company insiders that own Colfax stock include Brady Shirley, Christopher M Hix, Daniel A Pryor, Douglas J Pitts, Jason Maclean, Liam Kelly, Matthew L Trerotola, Patricia A Lang, Rajiv Vinnakota and Shyam Kambeyanda.
View institutional ownership trends for Colfax
.

Which major investors are selling Colfax stock?

CFX stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Royce & Associates LP, Diamond Hill Capital Management Inc., Polar Capital Holdings Plc, Wedge Capital Management L L P NC, DAVENPORT & Co LLC, Private Management Group Inc., and Wexford Capital LP. Company insiders that have sold Colfax company stock in the last year include Christopher M Hix, Jason Maclean, Matthew L Trerotola, Patricia A Lang, and Shyam Kambeyanda.
View insider buying and selling activity for Colfax
or view top insider-selling stocks.

Which major investors are buying Colfax stock?

CFX stock was acquired by a variety of institutional investors in the last quarter, including Southpoint Capital Advisors LP, Oak Ridge Investments LLC, Artisan Partners Limited Partnership, BlackRock Inc., Jennison Associates LLC, Price T Rowe Associates Inc. MD, Federated Hermes Inc., and Fred Alger Management LLC. Company insiders that have bought Colfax stock in the last two years include Brady Shirley, and Liam Kelly.
View insider buying and selling activity for Colfax
or or view top insider-buying stocks.

How do I buy shares of Colfax?

Shares of CFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Colfax's stock price today?

One share of CFX stock can currently be purchased for approximately $43.52.

How much money does Colfax make?

Colfax has a market capitalization of $5.90 billion and generates $3.07 billion in revenue each year. The industrial products company earns $42.63 million in net income (profit) each year or $1.40 on an earnings per share basis.

How many employees does Colfax have?

Colfax employs 15,400 workers across the globe.

Does Colfax have any subsidiaries?

The following companies are subsidiares of Colfax: DJO Global.

When was Colfax founded?

Colfax was founded in 1995.

What is Colfax's official website?

The official website for Colfax is www.colfaxcorp.com.

Where are Colfax's headquarters?

Colfax is headquartered at 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701.

How can I contact Colfax?

Colfax's mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company can be reached via phone at 301-323-9000 or via email at [email protected]


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.